Global Product Portfolio
Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.
basiliximab
Simulect®
basiliximab
Immunology and Dermatology
Immunology and Dermatology
brimonidine tartrate
Simbrinza®
brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
brinzolamide
Simbrinza®
brinzolamide, brimonidine tartrate
Ophthalmology
Ophthalmology
carbidopa
Stalevo®
carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
entacapone
Stalevo®
carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
glycopyrronium bromide
Seebri Breezhaler®
glycopyrronium bromide
Respiratory
Respiratory
hyaluronic acid
Systane® Hydration
polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
levodopa
Stalevo®
carbidopa, levodopa, entacapone
Neuroscience
Established Medicines
octreotide acetate
Sandostatin LAR®
octreotide acetate
Oncology
Oncology
Sandostatin® SC
octreotide acetate
Oncology
Oncology
pasireotide
Signifor®
pasireotide
Oncology
Oncology
Signifor® LAR
pasireotide
Oncology
Oncology
polyethylene glycol 400
Systane® Hydration
polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Systane® Ultra
polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology
propylene glycol
Systane® Hydration
polyethylene glycol 400, propylene glycol, hyaluronic acid
Ophthalmology
Ophthalmology
Systane® Ultra
polyethylene glycol 400, propylene glycol
Ophthalmology
Ophthalmology